News & Analysis on Clinical Trial Services & Contract Research And Development
The world's first drug made from a genetically engineered goat has been given the thumbs up in Europe after being initially rejected in February. The decision has reopened the door for "pharming," where transgenic animals or plants are used to make drugs.
Looking for an edge in both proprietary and off-patent products, Plethora Solutions has licensed two drug delivery platforms from Maelor Pharmaceuticals and Metris Therapeutics in the UK.
Vaccine developer Iomai has solidified its position in transcutaneous immunisation (TCI) by receiving a new US patent which outlines methods for inducing an immune response to Iomai's novel skin-patch-based vaccines.
Millipore has unveiled new disposable Tangential Flow Filtration (TFF) assemblies that reduce validation efforts, increase process speed and mitigate risks.
Kuehne + Nagel's Irish arm has scored a new contract to manage the global logistics for Organon Ireland.
China's State Food and Drug Administration (SFDA) has authorised Shanghai Sunve Pharmaceutical and Yichang Changjiang Pharmaceutical to produce a licensed version of Roche's Tamiflu (oseltamivir phosphate), the first such approval in China.
Laboratory service provider, LabConnect has announced its intentions to expand into Central and Eastern Europe by adding Synevo Medicover Laboratory Services to its LabConnect network, becoming the first US-based central laboratory to do so.
The world's largest patient recruitment firm, Synexus Clinical Research has bagged its first Hungarian company in a bid to exploit the growing clinical trial opportunities in the emerging Eastern European market.